BASF has acquire Isobionics and partnered with Conagen, and will be launching biotech-based vanillin, nootkatone, and valencene. The company aims to advance technology for biotech-based aroma ingredients by combining its R&D experience and market access with the expertise of Isobionics and Conagen.
Isobionics develops and produces a range of natural ingredients for the F&F market, with a focus on citrus oil components. Toine Janssen, Founder, said in the release: “BASF is known for its high-quality standards, traceability and excellent regulatory know-how. By combining our biotech-based product portfolio and strong development pipeline with BASF’s expertise and its global market reach, we can provide the natural aroma ingredients market with even more innovations—and boost our growth.”
Conagen specializes in fermentation ingredients, with existing R&D and commercialization capabilities for this segment. The partnership will allow BASF to serve the market with natural vanillin, an aroma ingredient with a high market demand.